0 148

Cited 19 times in

Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial

DC Field Value Language
dc.contributor.author김동준-
dc.contributor.author김병문-
dc.contributor.author김영대-
dc.contributor.author김진권-
dc.contributor.author남효석-
dc.contributor.author박성하-
dc.contributor.author백민렬-
dc.contributor.author신나영-
dc.contributor.author유준상-
dc.contributor.author이경열-
dc.contributor.author이찬주-
dc.contributor.author이혜선-
dc.contributor.author정요한-
dc.contributor.author허지회-
dc.contributor.author허준녕-
dc.contributor.author이형우-
dc.contributor.author정재욱-
dc.contributor.author이일형-
dc.contributor.author임인환-
dc.contributor.author홍순호-
dc.date.accessioned2024-01-16T01:41:53Z-
dc.date.available2024-01-16T01:41:53Z-
dc.date.issued2023-09-
dc.identifier.issn0098-7484-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/197725-
dc.description.abstractImportance Optimal blood pressure (BP) control after successful reperfusion with endovascular thrombectomy (EVT) for patients with acute ischemic stroke is unclear.,Objective To determine whether intensive BP management during the first 24 hours after successful reperfusion leads to better clinical outcomes than conventional BP management in patients who underwent EVT.,Design, Setting, and Participants Multicenter, randomized, open-label trial with a blinded end-point evaluation, conducted across 19 stroke centers in South Korea from June 2020 to November 2022 (final follow-up, March 8, 2023). It included 306 patients with large vessel occlusion acute ischemic stroke treated with EVT and with a modified Thrombolysis in Cerebral Infarction score of 2b or greater (partial or complete reperfusion).,Interventions Participants were randomly assigned to receive intensive BP management (systolic BP target <140 mm Hg; n=155) or conventional management (systolic BP target 140-180 mm Hg; n=150) for 24 hours after enrollment. Main Outcomes and MeasuresThe primary outcome was functional independence at 3 months (modified Rankin Scale score of 0-2). The primary safety outcomes were symptomatic intracerebral hemorrhage within 36 hours and death related to the index stroke within 3 months.,Results The trial was terminated early based on the recommendation of the data and safety monitoring board, which noted safety concerns. Among 306 randomized patients, 305 were confirmed eligible and 302 (99.0%) completed the trial (mean age, 73.0 years; 122 women [40.4%]). The intensive management group had a lower proportion achieving functional independence (39.4%) than the conventional management group (54.4%), with a significant risk difference (-15.1% [95% CI, -26.2% to -3.9%]) and adjusted odds ratio (0.56 [95% CI, 0.33-0.96]; P=.03). Rates of symptomatic intracerebral hemorrhage were 9.0% in the intensive group and 8.1% in the conventional group (risk difference, 1.0% [95% CI, -5.3% to 7.3%]; adjusted odds ratio, 1.10 [95% CI, 0.48-2.53]; P=.82). Death related to the index stroke within 3 months occurred in 7.7% of the intensive group and 5.4% of the conventional group (risk difference, 2.3% [95% CI, -3.3% to 7.9%]; adjusted odds ratio, 1.73 [95% CI, 0.61-4.92]; P=.31).,Conclusions and Relevance Among patients who achieved successful reperfusion with EVT for acute ischemic stroke with large vessel occlusion, intensive BP management for 24 hours led to a lower likelihood of functional independence at 3 months compared with conventional BP management. These results suggest that intensive BP management should be avoided after successful EVT in acute ischemic stroke.,Trial Registration ClinicalTrials.gov Identifier: NCT04205305,-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Medical Association-
dc.relation.isPartOfJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAcute Disease-
dc.subject.MESHAged-
dc.subject.MESHAntihypertensive Agents* / adverse effects-
dc.subject.MESHAntihypertensive Agents* / therapeutic use-
dc.subject.MESHBlood Pressure* / drug effects-
dc.subject.MESHCerebral Hemorrhage / etiology-
dc.subject.MESHEndovascular Procedures-
dc.subject.MESHFemale-
dc.subject.MESHFunctional Status*-
dc.subject.MESHHumans-
dc.subject.MESHIschemic Stroke* / drug therapy-
dc.subject.MESHIschemic Stroke* / surgery-
dc.subject.MESHMale-
dc.subject.MESHStroke / therapy-
dc.subject.MESHThrombectomy* / adverse effects-
dc.subject.MESHThrombectomy* / methods-
dc.subject.MESHTreatment Outcome-
dc.titleIntensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiology (영상의학교실)-
dc.contributor.googleauthorHyo Suk Nam-
dc.contributor.googleauthorYoung Dae Kim-
dc.contributor.googleauthorJoonNyung Heo-
dc.contributor.googleauthorHyungwoo Lee-
dc.contributor.googleauthorJae Wook Jung-
dc.contributor.googleauthorJin Kyo Choi-
dc.contributor.googleauthorIl Hyung Lee-
dc.contributor.googleauthorIn Hwan Lim-
dc.contributor.googleauthorSoon-Ho Hong-
dc.contributor.googleauthorMinyoul Baik-
dc.contributor.googleauthorByung Moon Kim-
dc.contributor.googleauthorDong Joon Kim-
dc.contributor.googleauthorNa-Young Shin-
dc.contributor.googleauthorBang-Hoon Cho-
dc.contributor.googleauthorSeong Hwan Ahn-
dc.contributor.googleauthorHyungjong Park-
dc.contributor.googleauthorSung-Il Sohn-
dc.contributor.googleauthorJeong-Ho Hong-
dc.contributor.googleauthorTae-Jin Song-
dc.contributor.googleauthorYoonkyung Chang-
dc.contributor.googleauthorGyu Sik Kim-
dc.contributor.googleauthorKwon-Duk Seo-
dc.contributor.googleauthorKijeong Lee-
dc.contributor.googleauthorJun Young Chang-
dc.contributor.googleauthorJung Hwa Seo-
dc.contributor.googleauthorSukyoon Lee-
dc.contributor.googleauthorJang-Hyun Baek-
dc.contributor.googleauthorHan-Jin Cho-
dc.contributor.googleauthorDong Hoon Shin-
dc.contributor.googleauthorJinkwon Kim-
dc.contributor.googleauthorJoonsang Yoo-
dc.contributor.googleauthorKyung-Yul Lee-
dc.contributor.googleauthorYo Han Jung-
dc.contributor.googleauthorYang-Ha Hwang-
dc.contributor.googleauthorChi Kyung Kim-
dc.contributor.googleauthorJae Guk Kim-
dc.contributor.googleauthorChan Joo Lee-
dc.contributor.googleauthorSungha Park-
dc.contributor.googleauthorHye Sun Lee-
dc.contributor.googleauthorSun U Kwon-
dc.contributor.googleauthorOh Young Bang-
dc.contributor.googleauthorCraig S Anderson-
dc.contributor.googleauthorJi Hoe Heo-
dc.contributor.googleauthorOPTIMAL-BP Trial Investigators-
dc.identifier.doi10.1001/jama.2023.14590-
dc.contributor.localIdA00410-
dc.contributor.localIdA00498-
dc.contributor.localIdA00702-
dc.contributor.localIdA01012-
dc.contributor.localIdA01273-
dc.contributor.localIdA01512-
dc.contributor.localIdA05987-
dc.contributor.localIdA02089-
dc.contributor.localIdA02513-
dc.contributor.localIdA02648-
dc.contributor.localIdA03238-
dc.contributor.localIdA03312-
dc.contributor.localIdA03659-
dc.contributor.localIdA04369-
dc.relation.journalcodeJ01196-
dc.identifier.eissn1538-3598-
dc.identifier.pmid37668619-
dc.identifier.urlhttps://jamanetwork.com/journals/jama/fullarticle/2808993-
dc.subject.keywordASSOCIATION-
dc.subject.keywordBRAIN EDEMA-
dc.subject.keywordGUIDELINES-
dc.subject.keywordIMPORTANT DIFFERENCE-
dc.subject.keywordINDIVIDUAL PATIENT DATA-
dc.subject.keywordMANAGEMENT-
dc.subject.keywordOUTCOMES-
dc.subject.keywordSCORE-
dc.subject.keywordTHERAPY-
dc.contributor.alternativeNameKim, Dong Joon-
dc.contributor.affiliatedAuthor김동준-
dc.contributor.affiliatedAuthor김병문-
dc.contributor.affiliatedAuthor김영대-
dc.contributor.affiliatedAuthor김진권-
dc.contributor.affiliatedAuthor남효석-
dc.contributor.affiliatedAuthor박성하-
dc.contributor.affiliatedAuthor백민렬-
dc.contributor.affiliatedAuthor신나영-
dc.contributor.affiliatedAuthor유준상-
dc.contributor.affiliatedAuthor이경열-
dc.contributor.affiliatedAuthor이찬주-
dc.contributor.affiliatedAuthor이혜선-
dc.contributor.affiliatedAuthor정요한-
dc.contributor.affiliatedAuthor허지회-
dc.citation.volume330-
dc.citation.number9-
dc.citation.startPage832-
dc.citation.endPage842-
dc.identifier.bibliographicCitationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.330(9) : 832-842, 2023-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.